1. Guo, G, Ye, L, Pan, K, et al. New insights of emerging SARS-CoV-2: epidemiology, etiology, clinical features, clinical treatment, and prevention. Front Cell Dev Biol. 2020;8:410.
Google Scholar | Crossref | Medline2. Cucinotta, D, Vanelli, M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157-160.
Google Scholar | Medline3. Accessed September 27, 2020. https://covid19.who.int/
Google Scholar4. Martini, N, Piccinni, C, Pedrini, A, Maggioni, A. CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project. Recenti Prog Med. 2020;111:198-201.
Google Scholar | Medline5. Medsger, TA . Systemic sclerosis (scleroderma): clinical aspect. In: Koopman, WJ , ed. Arthritis and Allied Conditions. A Textbook of Rheumatology. Philadelphia, PA: Williams & Wilkins; 2005:1433-1465.
Google Scholar6. Ferri, C, Giuggioli, D, Raimondo, V, et al. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020;39:3195-3204.
Google Scholar | Crossref | Medline7. Orlandi, M, Lepri, G, Bruni, C, et al. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol. 2020;39:2043-2047.
Google Scholar | Crossref | Medline8. Salvarani, C, Bajocchi, G, Mancuso, P, et al. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020;79:986-988.
Google Scholar | Crossref | Medline9. EULAR guidance for patients during Covid-19 outbreak . Accessed April 27, 2020. https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm
Google Scholar10. ACR guidance for patients during Covid-19 outbreak . Accessed April 28, 2020. https://www.rheumatology.org/announcements
Google Scholar11. Matucci Cerinic, M, Bruni, C, Allanore, Y, et al. Systemic sclerosis and the SARS2-COVID-19 virus pandemic: World Scleroderma Foundation preliminary advices for patient management. Ann Rheum Dis. 2020;79:724-726.
Google Scholar | Crossref | Medline12. Accessed May, 2020. https://salute.regione.emiliaromagna.it/@@search?SearchableText=HUB+sclerosi+sistemica
Google Scholar13. Ferri, C, Valentini, G, Cozzi, F, et al. Systemic sclerosis study group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139-153.
Google Scholar | Crossref | Medline | ISI14. Ferri, C, Sebastiani, M, Lo Monaco, A, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev. 2014;13:1026-1034.
Google Scholar | Crossref | Medline15. Denton, CP, Black, CM, Abraham, DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2:134-144.
Google Scholar | Crossref | Medline16. Ferri, C, Giuggioli, D, Guiducci, S, et al. Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum. Clin Exp Rheumatol. 2020;38:40-47.
Google Scholar | Medline17. Pignatti, M, Spinella, A, Cocchiara, E, et al. Autologous fat grafting for the oral and digital complications of systemic sclerosis: results of a prospective study. Aesthetic Plast Surg. 2020;44:1820-1832.
Google Scholar | Crossref | Medline18. Accessed May, 2020. https://reconnet.ern-net.eu/disease_ssc/
Google Scholar19. Accessed May, 2020. http://www.salute.gov.it/portale/nuovocoronavirus/homeNuovoCoronavirus.jsp?lingua=english
Google Scholar20. Accessed May, 2020. https://www.reumatologia.it/cmsx.asp?IDPg=1107
Google Scholar